Undervalued Dividend Growth Stock of the Week: AbbVie Inc. (ABBV)
This is a high-quality and growing firm with a blockbuster drug in its arsenal. It’s growing well above average, it pays a 3.8% yield, and it’s potentially 29% undervalued…
Read MorePosted by Jason Fieber, Dividends And Income | Apr 30, 2017
This is a high-quality and growing firm with a blockbuster drug in its arsenal. It’s growing well above average, it pays a 3.8% yield, and it’s potentially 29% undervalued…
Read MorePosted by Jason Fieber, Dividends And Income | Apr 23, 2017
This appears to be one of the more interesting and undervalued dividend growth stocks available at this time, and it’s absolutely worth a good look right now…
Read MorePosted by Jason Fieber, Dividends And Income | Apr 16, 2017
With shares potentially 13% undervalued today, plenty of room for huge dividend increases, and the chance to invest alongside Warren Buffett, this is a dividend growth stock that merits consideration…
Read MorePosted by Jason Fieber, Dividends And Income | Apr 9, 2017
With more than two decades of dividend increases, huge dividend raises predicted for the next seven years, a massive yield, and shares potentially 14% undervalued, long-term dividend growth investors ought to take a good look at this stock right now…
Read MorePosted by Jason Fieber, Dividends And Income | Apr 2, 2017
In addition to its monstrous yield, I think this stock’s valuation is extremely compelling right now…
Read More